missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novobiocin Sodium Salt, MP Biomedicals™
Description
Inhibits DNA synthesis by inhibiting the enzyme Topoisomerase II. Novobiocin Sodium Salt, MP Biomedicals is an antibiotic produced by Streptomyces nieveus. It is active against gram-positive bacteria. It is also a Hsp90 inhibitor 3.
Novobiocin inhibits DNA synthesis by inhibiting bacterial DNA gyrase targeting the GyrB subunit of the enzyme involved in energy transduction. It acts as a competitive inhibitor of the ATPase reaction catalysed by GyrB 2. Uses include:
- For the production of positively supercoiled plasmid DNA
- Inhibitor of bacterial DNA gyrase and eukaryotic DNA topoisomerase
- Inhibitor of retrovirus RNA-dependent DNA-polymerase
- To study heat shock protein inhibition
Specifications
Specifications
| Physical Form | Powder |
| Absorbance | λ max: 307nm |
| Melting Point | 220°C |
| Extinction Coefficient | E1%= 600 (0.1M NAOH) |
| Potency | ∼900μg/mg |
| Quantity | 25 g |
| Optical Rotation | −38.0° (2.5g/100ml ethanol at 24°C for the free acid) |
| Solubility Information | Freely soluble in water (10%, clear, colorless solution) |
| IUPAC Name | [(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate;molecular hydrogen;sodium |
| Formula Weight | 634.6 |
Safety and Handling
| Recommended Storage | Store at 2–8°C. |